Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Net Cash Flow (2016 - 2025)

INVO Fertility (IVF) has disclosed Net Cash Flow for 15 consecutive years, with -$193290.0 as the latest value for Q3 2025.

  • On a quarterly basis, Net Cash Flow rose 62.42% to -$193290.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$72721.0, a 88.4% increase, with the full-year FY2024 number at $508972.0, up 257.7% from a year prior.
  • Net Cash Flow was -$193290.0 for Q3 2025 at INVO Fertility, up from -$291226.0 in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $2.1 million in Q1 2023 to a low of -$2.1 million in Q2 2023.
  • A 5-year average of -$512729.9 and a median of -$291226.0 in 2025 define the central range for Net Cash Flow.
  • Biggest YoY gain for Net Cash Flow was 213.72% in 2023; the steepest drop was 320.9% in 2023.
  • INVO Fertility's Net Cash Flow stood at $971752.0 in 2021, then plummeted by 120.12% to -$195562.0 in 2022, then tumbled by 320.9% to -$823120.0 in 2023, then skyrocketed by 138.0% to $312784.0 in 2024, then plummeted by 161.8% to -$193290.0 in 2025.
  • Per Business Quant, the three most recent readings for IVF's Net Cash Flow are -$193290.0 (Q3 2025), -$291226.0 (Q2 2025), and $99011.0 (Q1 2025).